Morphine Sul 8mg/ml Inj, 1ml
Overview
What is this medicine?
How to Use This Medicine
For proper storage and disposal of this medication, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to store it at home.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Avoid alcohol and other sedating medications (e.g., benzodiazepines, sleeping pills) unless specifically approved by your doctor, as this can lead to dangerous breathing problems or extreme drowsiness.
- Do not drive or operate heavy machinery until you know how morphine affects you, as it can cause dizziness and drowsiness.
- To prevent constipation, drink plenty of fluids, eat fiber-rich foods, and use a stool softener or laxative as directed by your doctor.
- Change positions slowly to avoid dizziness or lightheadedness, especially when getting up from a sitting or lying position.
Available Forms & Alternatives
Available Strengths:
- Morphine Sulf Rect 20mg Suppository
- Morphine Sul 10mg Rect Suppository
- Morphine Sulf Rect 30mg Suppository
- Morphine Sulf Rect 5mg Suppository
- Morphine Sul 15mg ER Tabs (12h)
- Morphine Sul 30mg ER Tabs (12h)
- Morphine Sul 60mg ER Tabs (12h)
- Morphine Sulf 100mg ER Tabs (12h)
- Morphine Sulf 200mg ER Tabs (12h)
- Morphine Sul 50mg/ml Inj , 20ml
- Morphine Sul 50mg/ml Inj, 50ml
- Morphine Sul 1mg/ml Inj 10ml
- Morphine Sul 30mg Imm Rel Tab
- Morphine Sul 15mg Imm Rel Tab
- Morphine Sul 10mg/5ml(2mg/ml) Sol
- Morphine Sul 20mg/5ml(4mg/ml) Sol
- Morphine Sulf 100mg/5ml(20mg/ml)sol
- Morphine Sul 10mg/ml Inj, 1ml
- Morphine Sul 10mg ER Caps (24h)
- Morphine Sul 30mg ER Caps (24h)
- Morphine Sul 60mg ER Caps (24h)
- Morphine Sul 45mg ER Caps (24h)
- Morphine Sul 75mg ER Caps (24h)
- Morphine Sul 90mg ER Caps (24h)
- Morphine Sulf 120mg ER Caps (24h)
- Morphine Sul 80mg ER Caps (24h)
- Morphine Sul 30mg ER Caps (24h)
- Morphine Sul 20mg ER Caps(24h)
- Morphine Sul 50mg ER Caps(24h)
- Morphine Sulf 100mg ER Caps (24h)
- Morphine Sul 4mg/ml Inj, 1ml
- Morphine Sulf 100mg/5ml(20mg/ml)sol
- Morphine Sulfate 2mg/ml Inj 1ml
- Morphine Sulf Inj 4mg/ml 1ml Syr
- Morphine Sul 2mg/ml Inj 1ml
- Morphine Sul 8mg/ml Inj, 1ml
- Morphine Sul 30mg ER Tabs
- Morphine Sulfate 4mg/ml Inj, 1ml
- Morphine Sulfate 10mg/ml Inj, 1ml
- Morphine Sul 0.5mg/ml Inj, 5ml
- Morphine Sul 8mg/ml Inj, 1ml Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness or lightheadedness
+ Headache or feeling sleepy or weak
+ Shaking or rapid heartbeat
+ Confusion, hunger, or sweating
Severe dizziness or fainting
Chest pain or pressure, or a rapid heartbeat
Confusion or disorientation
Breathing difficulties, such as:
+ Slow or shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Seizures
Severe constipation or stomach pain, which may indicate a bowel problem
Depression or mood changes
Swelling in the arms or legs
Fever, chills, or sore throat
Painful urination
Abnormal sensations, such as burning, numbness, or tingling
Serotonin syndrome, a potentially life-threatening condition, characterized by:
+ Agitation or changes in balance
+ Confusion or hallucinations
+ Fever or rapid heartbeat
+ Flushing or muscle twitching or stiffness
+ Seizures or shivering
+ Excessive sweating, diarrhea, or vomiting
+ Severe headache
Adrenal gland problems, which may cause:
+ Extreme fatigue or weakness
+ Fainting or severe dizziness
+ Upset stomach, vomiting, or decreased appetite
Hormonal changes, including:
+ Decreased sex drive
+ Fertility problems
+ Irregular menstrual periods or ejaculation problems
Additional Side Effects (Injection into the Spine)
If you receive this medication via spinal injection, watch for:
Loss of muscle movement
Muscle spasms
Difficulty controlling body movements
Urination problems
Other Possible Side Effects
While many people may not experience side effects, some may encounter mild or moderate symptoms. If you notice any of the following, contact your doctor or seek medical attention if they persist or bother you:
Dizziness, drowsiness, fatigue, or weakness
Dry mouth
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Headache
Anxiety
Excessive sweating
Reporting Side Effects
If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Slow or shallow breathing
- Extreme drowsiness or difficulty waking up
- Severe dizziness or lightheadedness
- Confusion
- Bluish lips or fingernails
- Pinpoint pupils
- Severe constipation or abdominal pain
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
To ensure safe treatment, inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Describe the allergic reaction you experienced, including the symptoms that occurred.
Existing health conditions, such as:
+ Respiratory problems (e.g., asthma, breathing difficulties, sleep apnea)
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Recent use (within the last 14 days) of certain medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of the following medications: buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Additional Considerations for Spinal Injection:
Presence of an infection at the injection site
Bleeding disorders
* Use of blood thinners
This list is not exhaustive. It is essential to inform your doctor and pharmacist about all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions to verify the safety of taking this medication. Do not initiate, discontinue, or adjust the dosage of any medication without consulting your doctor.
Precautions & Cautions
To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position. Be cautious when climbing stairs.
Do not combine this medication with other potent pain relievers or use a pain patch without first consulting your doctor. If your pain worsens, you become more sensitive to pain, or experience new pain after taking this medication, contact your doctor immediately. Adhere to the prescribed dosage and do not exceed it.
Prolonged or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses are required to achieve the same effect. If you find that this medication is no longer working as well as it should, consult your doctor. Do not increase your dosage without medical guidance.
Long-term or regular use of opioid medications like this one can cause dependence. Suddenly reducing the dose or stopping the medication may increase the risk of withdrawal or other severe complications. Before changing your dosage or discontinuing the medication, consult your doctor and follow their instructions. Report any increased pain, mood changes, suicidal thoughts, or other adverse effects to your doctor.
If you have a sulfite allergy, discuss this with your doctor, as some products contain sulfites. Avoid consuming alcohol or using products that contain alcohol, as this can lead to unsafe and potentially fatal interactions.
This medication may increase the risk of seizures in certain individuals, including those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek immediate medical attention if your baby appears excessively sleepy, limp, or has breathing difficulties.
Overdose Information
Overdose Symptoms:
- Slowed or stopped breathing (respiratory depression)
- Extreme drowsiness or unresponsiveness
- Pinpoint pupils
- Cold, clammy skin
- Limp muscles
- Bluish discoloration of lips and fingernails
- Slowed heart rate
- Low blood pressure
- Coma
What to Do:
Seek immediate emergency medical attention. Call 911 or your local emergency number. If naloxone (Narcan) is available and you are trained to use it, administer it as directed while waiting for emergency help. Stay with the person and monitor their breathing until help arrives. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Contraindicated Interactions
- Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOIs (risk of serotonin syndrome, severe respiratory depression, coma, death)
- Patients with significant respiratory depression
- Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment
- Known or suspected paralytic ileus
- Hypersensitivity to morphine
Major Interactions
- Benzodiazepines and other CNS depressants (e.g., other opioids, sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, alcohol): Increased risk of profound sedation, respiratory depression, coma, and death.
- Mixed opioid agonist/antagonists (e.g., butorphanol, nalbuphine, pentazocine): May reduce the analgesic effect of morphine or precipitate withdrawal symptoms.
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, fentanyl): Risk of serotonin syndrome.
- Diuretics: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.
Moderate Interactions
- Anticholinergics (e.g., atropine, scopolamine): Increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.
- Muscle relaxants: Enhanced neuromuscular blocking action, leading to increased respiratory depression.
- Cimetidine: May inhibit morphine metabolism, leading to increased morphine levels and effects.
- Rifampin: May induce morphine metabolism, leading to decreased morphine levels and effects.
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline pain level and guide initial dosing.
Timing: Prior to first dose
Rationale: To assess baseline cardiorespiratory status and identify contraindications or risk factors for adverse effects.
Timing: Prior to first dose
Rationale: To assess baseline neurological status and risk of over-sedation.
Timing: Prior to first dose
Rationale: To assess baseline bowel habits and anticipate opioid-induced constipation.
Timing: Prior to first dose
Rationale: To identify impairment that may necessitate dose adjustment due to altered metabolism or excretion.
Timing: Prior to initiation, especially in patients with known or suspected impairment
Routine Monitoring
Frequency: Every 1-4 hours (acute pain); as needed or per protocol (chronic pain)
Target: Patient-specific pain goal (e.g., 0-3/10)
Action Threshold: Pain above target goal, requiring additional dose or intervention
Frequency: Every 15-30 minutes initially after IV dose, then every 1-4 hours or per protocol
Target: >10-12 breaths/min (adults), age-appropriate for pediatric
Action Threshold: <10 breaths/min (adults), shallow breathing, or signs of respiratory distress; administer naloxone, provide respiratory support
Frequency: Every 15-30 minutes initially after IV dose, then every 1-4 hours or per protocol
Target: Alert or mildly drowsy, easily aroused
Action Threshold: Difficult to arouse, somnolent, or unarousable; hold dose, administer naloxone, provide respiratory support
Frequency: Every 1-4 hours or per protocol
Target: Within patient's normal range
Action Threshold: Significant hypotension or bradycardia
Frequency: Daily
Target: Regular bowel movements
Action Threshold: No bowel movement for 2-3 days; initiate or escalate bowel regimen
Symptom Monitoring
- Nausea
- Vomiting
- Pruritus
- Dizziness
- Constipation
- Urinary retention
- Confusion
- Miosis (pinpoint pupils)
Special Patient Groups
Pregnancy
Prolonged use of morphine during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS), which may be life-threatening if not recognized and treated. Morphine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Morphine is excreted in breast milk. Monitor infants for signs of sedation, respiratory depression, poor feeding, and withdrawal symptoms. A single dose is generally considered low risk, but chronic use is not recommended. Consider alternative analgesics or pump and dump if chronic use is necessary.
Pediatric Use
Use with extreme caution, especially in neonates and infants, due to increased sensitivity to respiratory depression and variable pharmacokinetics. Dosing must be individualized and carefully titrated based on weight, age, and clinical response. Close monitoring for adverse effects is crucial.
Geriatric Use
Elderly patients may be more sensitive to the analgesic and adverse effects of morphine, particularly respiratory depression, sedation, and constipation. Start with lower doses and titrate slowly. Monitor renal function closely as clearance may be reduced.
Clinical Information
Clinical Pearls
- Always have naloxone readily available when administering morphine, especially in opioid-naive patients or when titrating doses.
- Opioid-induced constipation is a common and persistent side effect; prophylactic bowel regimen (stimulant laxative + stool softener) should be initiated with chronic use.
- Titrate dose slowly to achieve adequate pain relief while minimizing adverse effects, especially respiratory depression and sedation.
- Assess pain and sedation levels frequently, particularly after initial doses or dose adjustments.
- Be aware of the potential for tolerance and physical dependence with prolonged use; do not abruptly discontinue after chronic use to avoid withdrawal symptoms.
- In patients with renal impairment, accumulation of the active metabolite (M6G) can lead to prolonged and exaggerated opioid effects; dose reduction and extended dosing intervals are crucial.
Alternative Therapies
- Other strong opioid analgesics (e.g., hydromorphone, fentanyl, oxycodone)
- Non-opioid analgesics (e.g., NSAIDs, acetaminophen, gabapentin, pregabalin)
- Regional anesthesia (e.g., nerve blocks, epidural analgesia)
- Adjuvant analgesics (e.g., antidepressants, muscle relaxants)
- Non-pharmacological pain management (e.g., physical therapy, acupuncture, cognitive behavioral therapy)
Cost & Coverage
General Drug Facts
This medication is accompanied by a Medication Guide, a patient fact sheet that provides important information about its use. It is crucial to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, consult with your doctor, pharmacist, or other healthcare provider.
In the event of an overdose, a medication called naloxone can be used as an emergency treatment. Discuss with your doctor or pharmacist how to obtain or use naloxone, as it can help reverse the effects of an overdose. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about the overdose, including the medication taken, the amount, and the time it occurred, to help healthcare providers deliver appropriate care.